✨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 91
16 JUNE 2005
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Athlete’s Foot Cream
Active Ingredient:
Terbinafine hydrochloride 1%w/w
Dosage Form:
Topical cream
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Cipla Limited, Patalganga, District Raigad, (Maharashtra), India
Product:
Demazin Infant Clear Syrup
Active Ingredients:
Chlorpheniramine maleate 0.25mg/mL
Phenylephrine hydrochloride 0.5mg/mL
Dosage Form:
Syrup
New Zealand Sponsor:
Schering-Plough Animal Health Limited
Manufacturer:
Schering-Plough Pty Limited, Baulkham Hills, New South Wales, Australia
Product:
Dermafex Cream
Active Ingredient:
Terbinafine hydrochloride 1%w/w
Dosage Form:
Topical cream
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Cipla Limited, Patalganga, District Raigad, (Maharashtra), India
Dated this 9th day of June 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go3675
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Eprex (notification received 4 June 2004)
Active Ingredient:
Epoetin alfa 84µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Product:
Eprex (notification received 4 June 2004)
Active Ingredient:
Epoetin alfa 16.8µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Product:
Eprex (notification received 4 June 2004)
Active Ingredient:
Epoetin alfa 33.6µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 91
Gazette.govt.nz —
NZ Gazette 2005, No 91
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare9 June 2005
Medicines Act 1981, New medicines, Distribution consent, Health
- DON MATHESON, Deputy Director-General, Public Health
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social WelfareMedicines Act 1981, Changed medicines, Distribution consent, Health